Travel Health and Vaccines Slideshow Pictures

Medical Author:

Mai Kim Lai, MD

Coauthor:

Douglas C Finefrock, DO

Coauthor:

Gregory L Walker, MD, FACEP, Ped EM

Medical Editor:

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, Chief Medical Editor

Melissa Conrad Stöppler, MD, is a U.S. board-certified Anatomic Pathologist with subspecialty training in the fields of Experimental and Molecular Pathology. Dr. Stöppler's educational background includes a BA with Highest Distinction from the University of Virginia and an MD from the University of North Carolina. She completed residency training in Anatomic Pathology at Georgetown University followed by subspecialty fellowship training in molecular diagnostics and experimental pathology.

View Full Profile

Human Papillomavirus (HPV) Vaccine

HPV infection is considered to be the most common sexually transmitted infection (sexually transmitted disease, STD) in the U.S. It is estimated that at least 75% of the reproductive-age population has been infected with sexually transmitted HPV at some point in life. It is believed that over 6 million people become infected with HPV every year in the U.S., and approximately 50% of those infected are between the ages of 15 and 25.

Although HPV infection may not cause symptoms, it is known that certain types of HPVs cause precancerous changes in the uterine cervix as well as cervical cancer. HPVs also cause genital warts.

• The human papillomavirus vaccine is recommended in a three-dose schedule with the second and third doses administered two and six months after the first dose. It is recommended for all women up to 26 years of age who have not completed the vaccine series.